124 related articles for article (PubMed ID: 38377985)
1. Revitalizing oncology medications access in Saudi Arabia: Current challenges and recommendations by the Saudi Oncology Pharmacy Assembly.
Alkhudair N; Howaidi J; Alnuhait M; Alshamrani M; Khan M; Alharbi A; Alnajjar F; Bajnaid E; Almodaheem H; Alhowimel M; Alzahrani A; Khardaly A; Alnahedh M; Elsoudi H; Alabdulkareem H; Alrashidan A; Alzahrani M; Alrajhi A
J Oncol Pharm Pract; 2024 Feb; ():10781552241232697. PubMed ID: 38377985
[TBL] [Abstract][Full Text] [Related]
2. A qualitative exploration of the major challenges facing pharmacovigilance in Saudi Arabia.
Aljadhey H; Mahmoud MA; Alshammari TM; Al-Dhaeefi M; Le Louet H; Perez-Gutthann S; Pitts PJ
Saudi Med J; 2015 Sep; 36(9):1097-102. PubMed ID: 26318468
[TBL] [Abstract][Full Text] [Related]
3. Assessing oncology providers attitudes and practices toward nonformulary drugs and mapping current obstacles in Saudi Arabia.
Alkhudair N; Alhifany AA; Alsubaie B; Alshubaiki L; Alrajhi AM; Alnuhait M
Saudi Pharm J; 2023 Dec; 31(12):101840. PubMed ID: 37961071
[TBL] [Abstract][Full Text] [Related]
4. Applying value-based strategies to accelerate access to novel cancer medications: guidance from the Oncology Health Economics Expert Panel in Qatar (Q-OHEP).
Hamad A; Elazzazy S; Bujassoum S; Rasul K; Gaziev J; Cherif H; Al-Boloshi Z; Hanssens Y; Saleh A; Rasheed HA; Al-Badriyeh D; Babiker A; Hmaidan AA; Al-Hail M
BMC Health Serv Res; 2023 Jan; 23(1):15. PubMed ID: 36609388
[TBL] [Abstract][Full Text] [Related]
5. Emerging Role of Biosimilars in Oncology-Hematology in Saudi Arabia: A Practical Perspective.
Khan MA; Aseeri MA; Alshamrani MA; Alnatsheh AH; Alhamdan HS
Glob J Qual Saf Healthc; 2020 Feb; 3(1):22-29. PubMed ID: 37440966
[TBL] [Abstract][Full Text] [Related]
6. Addressing Cancer Treatment Shortages in Saudi Arabia: Results of a National Survey and Expert Panel Recommendations.
AlAzmi AA; Jastaniah W; Alhamdan HS; AlYamani AO; AlKhudhyr WI; Abdullah SM; AlZahrani M; AlSahafi A; AlOhali TA; Alkhelawi T; AlObaida Y; Allam A; Al-Hashmi H; Murshid E; AlNajjar F; AlGethami A; AlHarbi A; AlFoheidi MO; AlSaeed AS; Elsolh H; Abosoudah I; Ben Obaid A; AlNahedh M
JCO Glob Oncol; 2020 Mar; 6():476-485. PubMed ID: 32202921
[TBL] [Abstract][Full Text] [Related]
7. Challenges to and the future of medication safety in Saudi Arabia: A qualitative study.
Aljadhey H; Mahmoud MA; Hassali MA; Alrasheedy A; Alahmad A; Saleem F; Sheikh A; Murray M; Bates DW
Saudi Pharm J; 2014 Sep; 22(4):326-32. PubMed ID: 25161376
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
[TBL] [Abstract][Full Text] [Related]
9. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
10. The Saudi consensus recommendations for the management of psoriatic arthritis (2023).
Al-Homood IA; Al Ghanim N; Fatani MIA; Hussein AH; Alolaiwi AM; Abualiat A; Alqurtas E; Alomari BAA; Khardaly AM; Alenzi KAO; Albarakati RG; Almudaiheem HY; Al-Jedai A; Eshmawi MTY
Clin Rheumatol; 2024 Mar; 43(3):879-894. PubMed ID: 38217738
[TBL] [Abstract][Full Text] [Related]
11. The role of pharmacoeconomics in formulary decision making in different hospitals in Riyadh, Saudi Arabia.
Alsultan MS
Saudi Pharm J; 2011 Jan; 19(1):51-6. PubMed ID: 23960742
[TBL] [Abstract][Full Text] [Related]
12. Practical strategies to manage cancer patients during the COVID-19 pandemic: Saudi Oncology Pharmacy Assembly Experts recommendations.
Alshamrani M; AlHarbi A; Alkhudair N; AlNajjar F; Khan M; Obaid AB; Khardaly A; Bajnaid E; Samarkandi H; AlAzmi A; Alabdali S; AlNahedh M
J Oncol Pharm Pract; 2020 Sep; 26(6):1429-1440. PubMed ID: 32580641
[TBL] [Abstract][Full Text] [Related]
13. Health consumer engagement in developing novel preventive health community pharmacy roles in cardiovascular disease in Saudi Arabia: A qualitative analysis.
Almansour HA; Aloudah NM; Alhawassi TM; Chaar B; Krass I; Saini B
Saudi Pharm J; 2020 May; 28(5):529-537. PubMed ID: 32435133
[TBL] [Abstract][Full Text] [Related]
14. The use of pharmacoeconomic evidence to support formulary decision making in Saudi Arabia: Methodological recommendations.
Al Aqeel SA; Al-Sultan M
Saudi Pharm J; 2012 Jul; 20(3):187-94. PubMed ID: 23960792
[TBL] [Abstract][Full Text] [Related]
15. Cancer Management in Saudi Arabia: Recommendations by the Saudi Oncology HeAlth Economics ExpeRt GrouP (SHARP).
Alkhudair N; Alshamrani M; Samarkandi H; Almodaheem H; Alabdulkarim H; Alsaqaaby M; Alnajjar F; Alhashem H; Bakkar M; Bazarbashi S; Alnahedh M; Alfraih F; Alawagi M; Al-Jedai A
Saudi Pharm J; 2021 Feb; 29(2):115-120. PubMed ID: 33679175
[TBL] [Abstract][Full Text] [Related]
16. Challenges and Suggested Solutions for Functional Neurosurgery Practitioners and Patients in Saudi Arabia: Cross-Sectional Study.
Aleid A
Cureus; 2023 Aug; 15(8):e44323. PubMed ID: 37654904
[TBL] [Abstract][Full Text] [Related]
17. Developing pharmacists' competencies in Saudi Arabia: A proposed national competency framework to support initial education and professional development.
Alfaifi S; Bridges S; Arakawa N
Curr Pharm Teach Learn; 2022 Oct; 14(10):1256-1268. PubMed ID: 36280556
[TBL] [Abstract][Full Text] [Related]
18. National Guidelines for Colorectal Cancer Screening in Saudi Arabia with strength of recommendations and quality of evidence.
Alsanea N; Almadi MA; Abduljabbar AS; Alhomoud S; Alshaban TA; Alsuhaibani A; Alzahrani A; Batwa F; Hassan AH; Hibbert D; Nooh R; Alothman M; Rochwerg B; Alhazzani W; Morgan RL
Ann Saudi Med; 2015; 35(3):189-95. PubMed ID: 26409792
[TBL] [Abstract][Full Text] [Related]
19. Overview of Procurement and Reimbursement of Pharmaceuticals in Saudi Arabia, United Arab Emirates, Qatar, and Egypt: Challenges and Opportunities.
Hamad A; Alsaqa'aby M; Alruthia Y; Aldallal S; Elsisi GH
Glob J Qual Saf Healthc; 2023 Nov; 6(4):127-136. PubMed ID: 38404458
[TBL] [Abstract][Full Text] [Related]
20. Addressing medication errors in an adult oncology department in Saudi Arabia: A qualitative study.
Alharbi W; Cleland J; Morrison Z
Saudi Pharm J; 2019 Jul; 27(5):650-654. PubMed ID: 31297019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
